Skip to main content
. 2017 Sep 15;29(9):1675–1679. doi: 10.1589/jpts.29.1675

Table 2. Changes in pain, HRQoL, and fall risk among treatment groups.

HILT + EX PL + EX HILT PL




Pre 12 W Pre 12 W Pre 12 W Pre 12 W
Pain level (VAS)* 5.6 ± 1.2 0.7 ± 0.5** 5.3 ± 1.0 1.8 ± 0.7** 5.1 ± 1.0 1.1 ± 0.7** 5.2 ± 1.2 3.6 ± 0.9**
HRQoL* 47.8 ± 5.2 22.5 ± 4.6** 46.2 ± 4.6 28.4 ± 5.5** 45.3 ± 4.4 35.2 ± 5.6** 44.6 ± 5.3 42.4 ± 3.7**
Fall risk* 3.2 ± 0.6 2.2 ± 0.5 2.9 ± 0.9 2.5 ± 0.8 3.2 ± 0.8 3.1 ± 0.7 3.0 ± 0.9 2.9 ± 0.9**

HILT: high intensity laser therapy; EX: exercises; PL: placebo laser; 12 W: 12 weeks, VAS: visual analogue scale, HRQoL: health related quality of life. Data are expressed as mean ± standard deviation. *Significant difference in the post treatment measurement among treatment groups. **Significant difference in each treatment group in post treatment as compared to baseline values.